We are live on ! Find out more
PFM Health Sciences

PFM Health Sciences Portfolio holdings

AUM $1B Turnover 54.4%
1-Year Est. Return 77.91%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+77.91%
3 Year Est. Return
+264.51%
5 Year Est. Return
+347.39%
10 Year Est. Return
+2,853.52%
AUM
$1B
AUM Growth
-$163M
Cap. Flow
-$192M
Cap. Flow %
-19.11%
Top 10 Hldgs %
34.22%
Holding
125
New
27
Increased
26
Reduced
29
Closed
41
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
1 year
Top 20 Avg Time Held Equity + Options
0.9 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
1.1 years
Top 20 Avg Time Held Equity only
0.9 years

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.6M
2
CNMD icon
CONMED
CNMD
+$14.9M
3
ZBH icon
Zimmer Biomet
ZBH
+$14.7M
4
GKOS icon
Glaukos
GKOS
+$13.4M
5
SUPN icon
Supernus
SUPN
+$12.9M

Top Sells

Rank Stock Value
1
PEN icon
Penumbra
PEN
+$19M
2
SYK icon
Stryker
SYK
+$17.8M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$17.7M
4
MTD icon
Mettler-Toledo International
MTD
+$17M
5
HUM icon
Humana
HUM
+$16.8M

Sector Composition

Rank Sector Weight
1 Healthcare 90.51%
2 Miscellaneous 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HSIC icon
101
Henry Schein
HSIC
$9.36B
– –
-134,423
Closed -$11.2M –
ILMN icon
102
Illumina
ILMN
$30.3B
– –
-35,040
Closed -$6.16M –
ITGR icon
103
Integer Holdings
ITGR
$4.32B
– –
-126,669
Closed -$11.8M –
LNTH icon
104
Lantheus
LNTH
$6.65B
– –
-146,403
Closed -$16.2M –
MGTX icon
105
MeiraGTx Holdings
MGTX
$868M
– –
-455,286
Closed -$6.15M –
MIRM icon
106
Mirum Pharmaceuticals
MIRM
$6.1B
– –
-31,536
Closed -$3.69M –
MLYS icon
107
Mineralys Therapeutics
MLYS
$1.3B
– –
-62,418
Closed -$1.68M –
MMSI icon
108
Merit Medical Systems
MMSI
$5.19B
– –
-197,038
Closed -$13.7M –
MRK icon
109
Merck
MRK
$360B
– –
-127,118
Closed -$16.3M –
MTD icon
110
Mettler-Toledo International
MTD
$34.3B
– –
-13,344
Closed -$17M –
NTRA icon
111
Natera
NTRA
$42.5B
– –
-22,077
Closed -$5.99M –
NVO icon
112
Novo Nordisk
NVO
$184B
– –
-265,016
Closed -$12.7M –
PEN icon
113
Penumbra
PEN
$12.6B
– –
-60,221
Closed -$19M –
QURE icon
114
uniQure
QURE
$1.54B
– –
-26,396
Closed -$1.22M –
RCUS icon
115
Arcus Biosciences
RCUS
$2.44B
– –
-152,129
Closed -$4.69M –
ROIV icon
116
Roivant Sciences
ROIV
$28.1B
– –
-268,008
Closed -$9.48M –
RZLT icon
117
Rezolute
RZLT
$340M
– –
-127,289
Closed -$662K –
SNDX icon
118
Syndax Pharmaceuticals
SNDX
$829M
– –
-118,422
Closed -$2.59M –
SYK icon
119
Stryker
SYK
$118B
– –
-56,637
Closed -$17.8M –
SYRE icon
120
Spyre Therapeutics
SYRE
$9.48B
– –
-46,217
Closed -$4.1M –
TARS icon
121
Tarsus Pharmaceuticals
TARS
$3.85B
– –
-40,579
Closed -$2.55M –
TNGX icon
122
Tango Therapeutics
TNGX
$4.18B
– –
-326,047
Closed -$10.2M –
TECX icon
123
Tectonic Therapeutic
TECX
$409M
– –
-45,631
Closed -$1.57M –
ORKA icon
124
Oruka Therapeutics
ORKA
$6.78B
– –
-158,825
Closed -$15.1M –
MBX icon
125
MBX Biosciences
MBX
$2.67B
– –
-70,971
Closed -$3.92M –

Similar funds

PFM Health Sciences's Q3 2026 Portfolio in Review

As of Q3 2026, PFM Health Sciences held 125 positions worth $1B, down 14% from $1.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences withdrew a net $192M in Q3 2026, closing 41 positions and reducing 29 holdings. Its most notable exit was Penumbra, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 99% a quarter earlier, followed by Miscellaneous.

Against the trend, PFM Health Sciences opened a new position in State Street SPDR S&P 500 ETF Trust worth $24.7M.

  • PFM Health Sciences's largest Q3 2026 buy was State Street SPDR S&P 500 ETF Trust: 32,421 shares worth $24.7M.
  • PFM Health Sciences added most to Supernus in Q3 2026, an estimated $12.9M increase.
  • PFM Health Sciences's biggest Q3 2026 reduction was Jazz Pharmaceuticals, cutting an estimated $17.7M.
  • PFM Health Sciences fully exited Penumbra in Q3 2026, selling an estimated $19M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $1B portfolio in Q3 2026.
  • PFM Health Sciences opened 27 new positions and closed 41 in Q3 2026.
  • PFM Health Sciences's portfolio value fell 14% quarter-over-quarter to $1B.

Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.